Background: Malaria represents one of the most important infectious disease
threats to deployed military forces; most personnel from developed countri
es are nonimmune personnel and are at high risk of infection and clinical m
alaria. This is especially true for forces deployed to highly-endemic areas
in Africa and Southeast Asia where drug-resistant malaria is common.
Methods:We conducted an outbreak investigation of malaria cases in Angola w
here a total of 439 nonimmune Brazilian troops were deployed for a 6-month
period in 1995-1996. A post-travel medical evaluation was also performed on
338 (77%) of the 439 soldiers upon return to Brazil. Questionnaire, medica
l record, thick/thin smear,and serum anti-Plasmodium falciparum antibody ti
ter (by IFA) data were obtained. Peak serum mefloquine (Mj and methylmefloq
uine (MM) metabolite levels were measured in a subsample of 66 soldiers (42
cases, 24 nonmalaria controls) who were taking weekly mefloquine prophylax
is (250 mg).
Results: Seventy-eight cases of malaria occurred among the 439 personnel in
itially interviewed in Angola (attack rate = 18%). Four soldiers were hospi
talized, and 3 subsequently died of cerebral malaria. Upon return to Brazil
, 63 (19%) of 338 soldiers evaluated were documented to have had clinical s
ymptoms and a diagnosis of malaria while in Angola. in addition, 37 (11%) a
symptomatically infected individuals were detected upon return (< 1% parasi
temia). Elevated, post-travel anti-P. falciparum IFA titers (<greater than
or equal to> 1:64) were seen in 101 (35%) of 292 soldiers tested, and was a
ssociated with a prior history of malaria in-country (OR = 3.67 95% Cl 1.98
-6.82, p < .001). Noncompliance with weekly mefloquine prophylaxis (250 mg)
was associated with a malaria diagnosis in Angola (OR = 3.75, 95% Cl 0.97-
17.41, p = .03) but not with recent P falciparum infection (by IFA titer).
Mean peak levels land ratios) of serum M and MM were also found to be lower
in those who gave a history of malaria while in Angola.
Conclusions: Malaria was a significant cause of morbidity among Brazilian A
rmy military personnel deployed to Angola. Mefloquine prophylaxis appeared
to protect soldiers from clinical, but not subclinical, Fl falciparum infec
tions. Mefloquine noncompliance and an erratic chemoprophylaxis prevention
policy contributed to this large outbreak in nonimmune personnel. This repo
rt highlights the pressing need for development of newer, more efficacious
and practical, prophylactic drug regimens that will reduce the malaria thre
at to military forces and travelers.